Gamma analysis dependence on specified low-dose thresholds for VMAT QA

Journal of Applied Clinical Medical Physics

Volumn 16, Issue 6, 2015, Pages 263-272

  Song, Ji Hye ^a   Kim, Min Joo ^a   Park, So Hyun ^a,b   Lee, Seu Ran ^a   Lee, Min Young ^a   Lee, Dong Soo ^b   Suh, Tae Suk ^a  

^a The Catholic University of Korea   (South Korea)

^b Uijeongbu St Mary's Hospital   (South Korea)

Author keywords

EPID; Gamma analysis; Low dose threshold; QA; VMAT

Indexed keywords

ALGORITHM; BRAIN NEOPLASMS; EVALUATION STUDY; HEAD AND NECK NEOPLASMS; HEALTH CARE QUALITY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; PROCEDURES; PROSTATIC NEOPLASMS; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING SYSTEM; STANDARDS; STATISTICS AND NUMERICAL DATA;

ALGORITHMS; BRAIN NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; PROSTATIC NEOPLASMS; QUALITY ASSURANCE, HEALTH CARE; RADIOMETRY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84949675192     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v16i6.5696     Document Type: Article

References (38)

1. Otto K. Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys. 2008;35(1):310-17.
2. Lee SR, Park JY, Suh TS, Park HJ, Lee JW, Jung WG. Impact of gamma analysis parameters on dose evaluation using Gafchromic EBT2 films. J Korean Phys Soc. 2012;61(8):1319-24.
3. Rajasekaran D, Jeevanandam P, Sukumar P, Ranganathan A, Johnjothi S, Nagarajan V. A study on correlation between 2D and 3D gamma evaluation metrics in patient-specific quality assurance for VMAT. Med Dosim. 2014;39(4):300-08.
4. Bedford JL and Warrington AP. Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys. 2009;73(2):537-45.
5. Betzel GT, Yi BY, Niu Y, Yu CX. Is RapidArc more susceptible to delivery uncertainties than dynamic IMRT? Med Phys. 2012;39(10):5882-90.
6. Greer PB. 3D EPID based dosimetry for pre-treatment verification of VMAT-methods and challenges. J Phys: Conf Ser. 2013;444(1):012010.
7. Hussein M, Rowshanfarzad P, Ebert MA, Nisbet A, Clark CH. A comparison of the gamma index analysis in various commercial IMRT/VMAT QA systems. Radiother Oncol. 2013;109(3):370-76.
8. Mancuso GM, Fontenot JD, Gibbons JP, Parker BC. Comparison of action levels for patient-specific quality assurance of intensity modulated radiation therapy and volumetric modulated arc therapy treatments. Med Phys. 2012;39(7):4378-85.
9. Bakhtiari M, Kumaraswamy L, Bailey DW, de Boer S, Malhotra HK, Podgorsak MB. Using an EPID for patient-specific VMAT quality assurance. Med Phys. 2011;38(3):1366-73.
10. Low DA, Harms WB, Mutic S, Purdy JA. A technique for the quantitative evaluation of dose distributions. Med Phys. 1998;25(5):656-61.
11. Stasi M, Bresciani S, Miranti A, Maggio A, Sapino V, Gabriele P. Pretreatment patient-specific IMRT quality assurance: a correlation study between gamma index and patient clinical dose volume histogram. Med Phys. 2012;39(12):7626-34.
12. Pulliam KB, Huang JY, Howell RM, et al. Comparison of 2D and 3D gamma analyses. Med Phys. 2014;41(2):021710.
13. Bresciani S, Dia AD, Maggio A, et al. Tomotherapy treatment plan quality assurance: The impact of applied criteria on passing rate in gamma index method. Med Phys. 2013;40(12):121711.
14. Ezzell GA, Burmeister JW, Dogan N, et al. IMRT commissioning: multiple institution planning and dosimetry comparisons, a report from AAPM Task Group 119. Med Phys. 2009;36(11):5359-73.
15. Nelms BE and Simon JA. A survey on planar IMRT QA analysis. J Appl Clin Med Phys. 2007;8(3):76-90.
16. Ezzell GA, Galvin JM, Low D, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT subcommittee of the AAPM radiation therapy committee. Med Phys. 2003;30(8):2089-115.
17. van Elmpt W, McDermott L, Nijsten S, Wendling M, Lambin P, Mijnheer B. A literature review of electronic portal imaging for radiotherapy dosimetry. Radiother Oncol. 2008;88(3):289-309.
18. Sharma DS, Mhatre V, Heigrujam M, Talapatra K, Mallik S. Portal dosimetry for pretreatment verification of IMRT plan: a comparison with 2D ion chamber array. J Appl Clin Med Phys. 2010;11(4):238-48.
19. Van Esch A, Depuydt T, Huyskens DP. The use of an aSi-based EPID for routine absolute dosimetric pre-treatment verification of dynamic IMRT fields. Radiother Oncol. 2004;71(2):223-34.
20. Das IJ, Cao M, Cheng CW, et al. A quality assurance phantom for electronic portal imaging devices. J Appl Clin Med Phys. 2011;12(2):391-403.
21. Varian Medical Systems. Eclipse Algorithm Reference Guide, P/N B500298R01C. Palo Alto, CA: Varian Medical Systems; 2007.
22. Van Esch A, Huyskens DP, Hirschi L. Optimized Varian aSi portal dosimetry: Development of datasets for collective use. J Appl Clin Med Phys. 2013;14(6):82-99.
23. Clemente S, Caivano R, Cozzolino M, et al. To evaluate the accuracy of dynamic versus static IMRT delivery using portal dosimetry. Clin Transl Oncol. 2014;16(2):208-12.
24. Howell RM, Smith IPN, Jarrio CS. Establishing action levels for EPID-based QA for IMRT. J Appl Clin Med Phys. 2008;9(3):16-25.
25. Varian Medical Systems. Portal Dosimetry Reference Guide, B502204R01. Palo Alto, CA: Varian Medical Systems; 2010.
26. Nelms BE, Chan MF, Jarry G, et al. Evaluating IMRT and VMAT dose accuracy: Practical examples of failure to detect systematic errors when applying a commonly used metric and action levels. Med Phys. 2013;40(11):111722.
27. Khan FM. The Physics of Radiation Therapy, fourth edition. Philadelphia: Lippincott Williams and Wilkins; 2010.
28. Hall EJ. Radiobiology for the Radiologist, fifth edition. Philadelphia: Lippincott Williams and Wilkins; 2000.
29. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6(8):557-65.
30. Barrett A, Dobbs J, Morris S, Roques T. Practical Radiotherapy Planning, fourth edition. London: Hodder Education; 2009.
31. Dörr W, Herrmann T. Cancer induction by radiotherapy: dose dependence and spatial relationship to irradiated volume. J Radiol Prot. 2002;22(3A):A117-21.
32. Dörr W and Herrmann T. Second primary tumors after radiotherapy for malignancies: Treatment-related parameters. Strahlenther Onkol. 2002;178(7):357-62.
33. Newhauser WD and Durante M. Assessing the risk of second malignancies after modern radiotherapy. Nat Rev Cancer. 2011;11(6):438-48.
34. Diallo I, Haddy N, Adjadj E, et al. Frequency distribution of second solid cancer locations in relation to the irradiated volume among 115 patients treated for childhood cancer. Int J Radiat Oncol Biol Phys. 2009;74(3):876-83.
35. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys. 2006;65(1):1-7.
36. Poppe B, Blechschmidt A, Djouguela A, et al. Two-dimensional ionization chamber arrays for IMRT plan verification. Med Phys. 2006;33(4):1005-15.
37. Kim JI, Park SY, Kim HJ, et al. The sensitivity of gamma-index method to the positioning errors of high-definition MLC in patient-specific VMAT QA for SBRT. Radiat Oncol. 2014;9(167):1-12.
38. Heilemann G, Poppe B, Laub W. On the sensitivity of common gamma-index evaluation methods to MLC misalignments in Rapidarc quality assurance. Med Phys. 2013;40(3):031702.